Skip to main content
15 articles related to "De Soto"

Articles

Original Research

Published on 20 Oct 2021

Experience of a Strategy Including CYP2C19 Preemptive Genotyping Followed by Therapeutic Drug Monitoring of Voriconazole in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation

in Pharmacogenetics and Pharmacogenomics

  • Lucía Martinez de Soto
  • Irene García-García
  • Irene Dapía
  • Jaime Montserrat
  • David Bueno
  • Lucía Díaz
  • Javier Queiruga
  • Amelia Rodriguez Mariblanca
  • Pilar Guerra-García
  • Elena Ramirez
Frontiers in Pharmacology
doi 10.3389/fphar.2021.717932
  • 4,344 views
  • 9 citations

Original Research

Published on 10 Mar 2022

Utility of Lymphocyte Transformation Test for Assisting Updated Roussel Uclaf Causality Assessment Method in Drug-Induced Liver Injury: A Case-Control Study

in Translational Pharmacology

  • Lucía Martínez de Soto
  • Amelia Rodríguez
  • Irene García-García
  • Arturo Gómez López De Las Huertas
  • Alberto M. Borobia
  • Andrea González-Torbay
  • Ibtissam Akatbach-Bousaid
  • Miguel González-Muñoz
  • Elena Ramírez
Frontiers in Pharmacology
doi 10.3389/fphar.2022.819589
  • 3,445 views
  • 14 citations

Original Research

Published on 16 Jan 2024

Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring

in Cancer Immunity and Immunotherapy

  • Concepción Pérez de Soto
  • Águeda Molinos-Quintana
  • Anna Alonso-Saladrigues
  • Blanca Herrero
  • Teresa Caballero-Velázquez
  • Víctor Galán-Gómez
  • Melissa Panesso
  • Montserrat Torrebadell
  • Javier Delgado-Serrano
  • Anna Faura
Frontiers in Immunology
doi 10.3389/fimmu.2023.1280580
  • 9,721 views
  • 19 citations

Correction

Published on 07 Feb 2024

Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring

in Cancer Immunity and Immunotherapy

  • Concepción Pérez de Soto
  • Águeda Molinos-Quintana
  • Anna Alonso-Saladrigues
  • Blanca Herrero
  • Teresa Caballero-Velázquez
  • Víctor Galán-Gómez
  • Melissa Panesso
  • Montserrat Torrebadell
  • Javier Delgado-Serrano
  • Anna Faura
Frontiers in Immunology
doi 10.3389/fimmu.2024.1373852
  • 2,119 views

Original Research

Published on 11 Sep 2024

Real-life experience with first-line treatment with daratumumab, bortezomib, melphalan, and prednisone in patients with newly diagnosed multiple myeloma ineligible for autologous stem-cell transplantation

in Blood Cancer

  • Teresa De Soto Álvarez
  • Amalia Domingo-González
  • Rafael Alonso Fernández
  • Ana Jiménez
  • Ana Lerma-Verdejo
  • Virginia Pradillo
  • Gonzalo Benzo Callejo
  • Jose Sánchez-Pina
  • Elena Landete
  • Alberto Velasco-Valdazo
Frontiers in Hematology
doi 10.3389/frhem.2024.1438233
  • 1,783 views

Original Research

Published on 18 Dec 2025

Impact of inotuzumab ozogamicin as bridging therapy and tumor burden in CAR-T therapy for B-acute lymphoblastic leukemia

in Cancer Immunity and Immunotherapy

  • Concepción Pérez de Soto
  • Patricia Alcalde-Mellado
  • Victoria Ruiz-Maldonado
  • Javier Delgado-Serrano
  • Luzalba Sanoja-Flores
  • Marta Reinoso-Segura
  • Laura Pérez-Ortega
  • Belén Sierro-Martínez
  • Estefanía García-Guerrero
  • José María Pérez-Hurtado
Frontiers in Immunology
doi 10.3389/fimmu.2025.1725878
  • 1,733 views